The following individuals have been invited to speak at the Tablet & Capsules Hands-On Short Course hosted by the University of Maryland School of Pharmacy.
Stephen Hoag, PhD
Professor of Pharmaceutical Sciences
Director, Good Manufacturing Practice Facility
University of Maryland School of Pharmacy
Dr. Hoag is a professor of pharmaceutical sciences at the University of Maryland School of Pharmacy. He received his PhD in pharmaceutics from the University of Minnesota-Twin Cities, and his BS in biochemistry from the University of Wisconsin-Madison. Dr. Hoag has been a visiting professor at 3M Pharmaceuticals and Abbott Laboratories. His primary research interests include excipient functionality testing, QbD, tablet coating, coating polymers, tablet press instrumentation, tablet compaction modeling, and formulation design. His research has included studies in formulation of folic acid in multivitamin and mineral supplements, formulation of botanical products, controlled release formulation, polymer science, pigment stability in coating polymers and thermal analysis of polymers, powder flow, and formulation stability. In collaboration with the Center for Veterinary Medicine at the Food and Drug Administration, Hoag has studied the application of near infrared spectroscopy to the analysis of excipient identification, tablet quality, and production monitoring for process analytical technology (PAT) applications. Working with Larry Augsburger, PhD, he has edited a three volume set of books on tablet compaction. Hoag is a member of the National Institute of Pharmaceutical Technology and Education (NIPTE) Executive Committee and has been elected to the USP Counsel of Experts. He is an AAPS fellow and serves on the International Steering Committee for the Handbook of Pharmaceutical Excipients and the editorial board of the Journal of Pharmaceutical Development Technology.
Larry Augsburger, PhD
University of Maryland School of Pharmacy
Before joining the University of Maryland faculty in 1969, Dr. Augsburger was a senior research scientist for Johnson & Johnson Services, Inc. of New Brunswick, NJ. During his time at the School, he served as the Shangraw Professor of Industrial Pharmacy and Pharmaceutics, chair of the Department of Pharmaceutics, and director of pharmaceutics graduate programs. A leader in original research that has enabled the modernization of some key US Food and Drug Administration (FDA) policies, Dr. Augsburger's achievements include directing University of Maryland-FDA collaborative research programs that supported the development of the critically important FDA guidances on scale-up and post-approval changes (SUPAC) for drugs in the market, through which he and his team showed that certain formulation and process changes in drug preparations, such as tablets and capsules, result in significant differences in how a drug is absorbed and becomes available to the human body in order to exert its therapeutic effect, while others do not. He also established the Drug Development Facility in the School, which later became UPM Pharmaceuticals, Inc., a University-affiliated for-profit firm for developing drugs and manufacturing clinical supplies founded in 1997. Though retired, Augsburger continues to write, consult, and observe the drug development industry.
Steven R. Aubuchon, PhD
Senior Territory Manager
TA Instruments-Waters, LLC
Steve Aubuchon is a senior territory manager at TA Instruments-Waters, LLC. He has been with TA Instruments since 1994, holding positions in applications management, product management, product development, and sales. Dr. Aubuchon earned his doctorate in inorganic physical chemistry from Duke University and his bachelor's degree in chemistry from St. Louis University. He has authored or co-authored more than 30 publications and delivered more than 150 invited lectures, seminars, and training courses in the field of thermal, mechanical, and rheological analysis of materials. His research interests focus on the characterization of polymeric and pharmaceutical structures, specifically time-dependent relaxation processes.
In addition to his work at TA Instruments, Dr. Aubuchon holds appointments as an affiliated professor in the Department of Materials Science and Engineering at the University of Delaware and as a visiting scientist in the Department of Chemistry at the University of Maryland, College Park.
Process Development Manager
GEA Process Engineering, Inc.
Andrew Birkmire is the pharmaceutical process development manager for GEA Process Engineering, Inc., the world leader in continuous powder processing. Birkmire's background includes extensive experience in coating, drying, and granulation technologies, with a focus on continuous manufacturing processes. He is currently in charge of the GEA Process Development Center in Columbia, Md.
Brian Carlin, PhD
Director, Open Innovation
Brian Carlin was the 2012 recipient of the IPEC Foundation Award for Industry Research Achievement in Excipient Technology. He is director of open innovation (Pharma) at FMC Health & Nutrition. He was previously the global manager of pharmaceutical R&D, and has been with FMC for 18 years. He chairs the IPEC Quality by Design and Excipient Composition Committees, and also serves on the USP Excipient Committee. Prior to joining FMC, he worked at SmithKline Beecham & Richardson Vicks in new product development for sixteen years. He obtained his doctorate in interfacial rheology from the School of Pharmacy, University of London, and an honours degree in pharmacy from the University of Aston in Birmingham. He serves on the distance learning MSc course in QbD at Demontfort University, UK, where he is an honorary visiting professor. He has been a leading advocate for innovative scientific approaches to excipients and pharmaceutics in pursuit of the QbD vision of the 21st century cGMP initiative.
Business Development Manager
Bosch North America
Simon studied industrial pharmaceutical science with applied chemistry at Liverpool John Moores University, England. Following the completion of his studies, he worked as a process scientist at Bosch-Manesty focusing on the development of tablet coating technology and compression. Later, he moved to Bosch-Hüttlin, again as a process scientist, but focusing on providing process support and optimization for fluid bed and high-shear systems. Simon’s current role as business development manager for North America includes providing technical support for customers in compression, tablet coating, pellet coating, and high shear/fluid bed granulation systems.
Regis Cazes, MS, MBA
Strategic Marketing Director
Regis Cazes is the strategic marketing director at MEDELPHARM in Lyon, France. He is in charge of global business development for the STYL’ONE™ Servo-Electric Tableting Instrument, a fully instrumented R&D press capable of mimicking virtually every rotary tablet presses and powered by a proprietary data acquisition and analysis software.
Previously, he worked in the pharmaceutical excipient business for 10 years, first in the film coating business as national sales manager at SEPPIC Inc., in New Jersey, then as head of the marketing and development team in the company's Paris headquarter. His areas of expertise include tablet film coatings, modeling of hydrophilic matrices, tableting excipients, tablet presses instrumentation, compression studies, and tablet characterizations.
Regis obtained his engineer diploma (MS) in physico-chemistry from the Graduate School of Bordeaux, France, and holds a MBA from the University of Lyon, France.
Senior Sales Engineer
Micromeritics Instrument Corporation
John Elter has more than 25 years of experience at Micromeritics working with instruments used in the material science field. His expertise involves BET surface area analysis and porosity by both gas adsorption and by mercury porosimetry. John also works with particle size analysis, including the techniques of static laser light scattering, particle counting, particle shape analysis, and dynamic light scattering. These techniques involve dispersion of many types of materials including pharmaceuticals. John has also worked extensively with gas pycnometry for true density analysis, TAP density, and geometric density. He currently supports customers in both the mid-Atlantic region as well as the New England region for sales, applications support, and instrument training. He is a current member of the American Chemical Society. He earned his BS in chemistry from Gannon University.
Gary Hollenbeck, PhD
Chief Scientific Officer, UPM Pharmaceuticals
Adjunct Professor of Pharmaceutical Sciences
University of Maryland School of Pharmacy
Dr. Hollenbeck has been a member of UPM's senior management team since its inception in 1997, and assumed the position of chief scientific officer on January 1, 2006. He serves as a key scientific and technical advisor at UPM and personally directs focused research and development projects in the area of novel drug delivery platforms. Dr. Hollenbeck also currently oversees the technical services, manufacturing, and materials management groups at the Baltimore facility. Prior to assuming this full-time position at UPM, he was a professor of pharmaceutical sciences at the University of Maryland School of Pharmacy. He received his Bachelor of Science from Albany College of Pharmacy and his doctorate in Industrial and Physical Pharmacy from Purdue University. Hollenbeck was associate dean for academic programs at the School of Pharmacy from 1991 to 1996, and was one of the principal architects of the School's nationally recognized Doctor of Pharmacy program. During that period, he was also co-principal investigator on the UMB/FDA Collaborative Agreement; a joint education, research and computer database effort aimed at establishing a scientific basis for review of new and amended drug applications. In this capacity, he and his associates received a special recognition award for the SUPAC IR Training Program, from the Center for Drug Evaluation and Research, FDA, PHS, DHHS. Dr. Hollenbeck also served as a member of the Advisory Committee on Pharmaceutical Science in the Office of Pharmaceutical Science at the FDA, and, in 2003, received a DHHS, FDA Commissioner's Special Citation for his work with the Center for Veterinary Medicine. Dr. Hollenbeck is a member of the editorial advisory board for Pharmaceutical Technology and continues to serve as an adjunct professor of pharmaceutical sciences at the School of Pharmacy.
Yidan Lan, PhD
BASF Pharma Solutions
Dr. Yidan Lan is a senior scientist at BASF Pharma Solutions, with more than 22 years experience in the pharmaceutical, polymer, and excipient industries. His current and previous work has focused on the areas of drug delivery, powder characterization, and formulation of solid and liquid dosage forms. Before joining BASF, Dr. Lan worked for Union Carbide, Dow Chemicals, Powerject Vaccines, and Chr Hansen Pharmaceutical Division. He earned his doctorate in the field of powder technology. In his current position, he is responsible for providing technical support to North American pharmaceutical industries and research institutes, supporting new product launches, and conducting research on the new applications of BASF excipients. His research interest includes drug layering, solid dispersion, microemulsion, ODT, solid and liquid taste masking, and micro encapsulation of vaccine and protein particles.
Darvin L. Martin
Northeast Regional Sales Manager
Natoli Engineering Company
With more than 15 years of experience in the pharmaceutical industry, Darvin Martin has supported formulators, scale-up manufacturing processes, and analytical quality control testing for tablets and capsules as well as non-traditional dosage forms. Darvin has degrees in agriculture and analytical chemistry, and began his career in pharmaceutical raw materials, developing numerous sample preparation methods for trace metal analysis utilizing ICP, ICP/MS, and AA instrumentation. He later expanded into various aspects of automated regulatory testing, including dissolution, disintegration, friability, tap/bulk density, and physical testing (weight/thickness/hardness) of tablets and capsules. At Natoli, he focusses on tablet press setup and standardizing procedures to improve the life-cycle of tablet presses and tooling.
Vikas Moolchandani, PhD
Senior Research Scientist
Nutrilite Health Institute (Amway)
Dr. Moolchandani is currently working as a senior research scientist at Nutrilite Health Institute (Amway) in Buena Park, CA, where he is responsible for the development of product and innovative formulation technologies for the Nutrilite brand supplements in the following categories: heart health, weight management, children's nutrition, and adult essential nutrition. Dr. Moolchandani's role is to execute all technical aspects of the product development process from pre-formulation to commercialization, utilizing current Good Manufacturing Practices (cGMP). He completed his PhD in Pharmaceutics at University of Maryland, Baltimore, and holds an MS in clinical science (topical drug delivery) from the University of Massachusetts, Lowell, and BS in pharmacy from the University of Bhopal, India. His overall research work is focused on the material characterization, product development in solid dosage forms like tablet, two piece hard capsules, softgel, sustained release tablet, as well as novel drug delivery systems (hydrogels, topical Nano emulsions, aerosol delivery) for small molecules, large molecules, dietary supplements and probiotics. He has collectively published more than 30 research papers and presentations and has co-authored two book chapters: (1) Tablet Compression and Compaction, In Pharmaceutical Dosage Forms: Tablets, Third Edition Volume 1: Unit Operations and Mechanical Properties, Informa Healthcare, New York, NY (April 2008) & (2) Capsule Filling Performance of Powdered Formulations in Relation to Flow Characteristics, Particulate Materials, Royal Society of Chemistry (RSC), UK (2011). He serves as reviewer for the following journals: Drug Development and Industrial Pharmacy, Journal of Pharmaceutical Sciences, and Pharmaceutical Research. He is also an active member of AAPS Nutraceuticals & Natural Products Chemistry Focus Group Steering Committee.
Susana Nieto, PhD
Susana Nieto is a consulting scientist at Medelpharm in Lyon, France. She works at the application laboratory of Medelpharm, using the Styl'One Tableting Instrument for characterization of solid formulations, APIs, and excipients for pharmaceutical, food, and chemical companies. Furthermore, she supports pharmaceutical industries on tableting scale-up and troubleshooting on compression issues. She also participates in the scientific marketing of Styl'One around the world through congress and workshops, as well as trainings for new Styl'One customers. She is a pharmacist and obtained her PhD from the School of Pharmacy of the University of Lille 2 in 2015. Her background includes formulation of oral solid dosage forms; coated pellets and hydrophobic matrix systems for controlled release of APIs; and compression studies.
Technical Sales Specialist
Lauren Petraglia has been involved with low pressure extrusion and spheronization since joining LCI Corporation in 2011. Her responsibilities include evaluation of potential applications, providing technical training presentations, scale-up from laboratory to production, system commissioning, and technical support. Prior to LCI she worked for PTI, Inc. delivering specialized technical and sales training to pharmaceutical salesman across the country. Petraglia holds a B.S. in Biology from the Pennsylvania State University.
Carmen Popescu, PhD
Senior Project Coordinator
Roquette America, Inc.
Dr. Carmen Popescu is a senior project coordinator at Roquette America Inc., located in Geneva, Illinois. She came to the USA in 1999 as an associate professor at the University of Illinois at Chicago, Pharmaceutics Department, where she is still an adjunct associate professor. Later, she moved to the pharmaceutical industry, working at Morton Grove Pharmaceutical, Baxter, and DeCode Genetics. In her career, she focused on classic dosage forms (liquid, semi-solid, and solid dosage forms formulation) as well as drug delivery systems (microparticles, nanoparticles, liposomes, niozome, etc.) for small and large molecules. She has published more than 120 research papers, book chapters, and presentations. She is also an adjunct associate professor with the University of Tennessee and Roosevelt University. She is a reviewer for the International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, and European Journal of Pharmaceutics and Biopharmaceutics. She is an active member of AAPS (Excipients Focus group and AAPS Chicagoland Discussion Group) and CRS.
Product Specialist, Spray Drying Segment
Debra Repko is the product specialist for the spray drying segment at Buchi Corporation. She has been supporting spray drying and encapsulation for Buchi since 2006. Her background consists of organic synthesis, formulation development and materials characterization of polymers. She has previously worked for AT&T Bell labs, DuPont, and DSM.
Field Service Engineer
Specialty Measurements, Inc.
Mark Rice is a field service engineer for Specialty Measurements, Inc. (SMI). He has been with SMI nearly 14 years. His responsibilities include tablet press instrumentation, commissioning, training, and calibration. Mark is also tasked with performing software validation services for "The Director" instrumentation systems as well as authoring and completing factory acceptance test documents and IQ/OQ protocols for Riva tablet presses. He has contributed to various posters and white papers that SMI has produced.
SMI offers The Director and Director Pro software instrumentation and tablet press control systems. SMI is the sole North American distributer for the Riva line of tablet presses and also offers Adamus HT tablet press punches and dies, tool polishing, and inspection machines, as well as a full line of tablet press spare parts.
NIR Marketing Manager
Denise Root is the NIR marketing manager at Metrohm USA. Denise is a chemist with more than 20 years of near-infrared experience in the roles of applications scientist, product management, and marketing. She is a graduate of the University of Delaware and has co-authored many posters and papers related to NIR application to the laboratory and process environments in the pharmaceutical and chemical industries.
Myke Scoggins, PhD
Manager, Process Development
Recro Gainesville, LLC
Dr. Myke Scoggins earned his BS in microbiology from the University of Georgia and PhD in pharmaceutical sciences from Mercer University. He has more than 20 years of experience in the pharmaceutical industry, including analytical chemistry, preformulation, formulation, process development and validation, scale-up, tech transfer, and manufacturing support. Prior to joining Recro, Dr. Scoggins worked in other pharmaceutical development environments on various dosage forms and delivery systems including tablets, capsules, transdermals, and osmotic systems. He has worked at an analytical instrument manufacturer, a medical device company managing microbial and chemical testing, generic pharmaceutical companies, larger international companies, and at a research university (Georgia Institute of Technology). He has delivered numerous lectures on topics in the pharmaceutical sciences to graduate students, helped develop graduate courses in pharmaceutical sciences at local universities, and presented research findings at national and international meetings. Dr. Scoggins is currently a member of AAPS, and sits on the USP Expert Committee for General Chapters – Physical Analysis with memberships on the Powders and Particles Sub-committees and the Nanotechnology Joint Sub-committee. He currently serves as process development manager at Recro Gainesville, LLC.
Director of Technical Training and Development
Natoli Engineering Company
Robert Sedlock is the Director of Technical Training and Development for Natoli Engineering Company. He has been serving the industry for over 18 years in the tablet compression arena. His early experience spans strain gauge force measurement technology and data acquisitions systems. Mr. Sedlock has many published technical papers in industry trade magazines and for American Association of Pharmaceutical Scientists. Areas of expertise include instrumentation systems, formulation optimization, compression studies and scale up. Mr. Sedlock is currently involved in many training seminars hosted by universities worldwide. His current responsibilities include tool / tablet designs, solid dosage troubleshooting and contract development work at the Natoli Institute of Industrial Pharmacy Research & Development located at Long Island University Arnold & Marie Schwartz College of Pharmacy and Health Sciences in Brooklyn, New York.
Timothy J. Smith, MS
Senior Process Development Scientist
Mr. Smith has been involved in the design and development of equipment and processes for the pharmaceutical, food, and confectionary industries for more than 30 years. Currently, he is serving as a senior process development scientist with Freund-Vector Corporation. Previously, he served as a research associate, application engineer, R&D engineer, and R&D project manager. Tim has given numerous presentations at seminars such as the University of Tennessee's tablet manufacturing short course, Colorcon, E&G, Evonik, FDA, Interphex, Lubrizol, TechSource, AAPS annual meetings, Freund-Vector's technical courses and numerous domestic/international customer facilities. He is the lead author of "Development, Scale-up, and Optimization of Process Parameters: Roller Compaction" (Chapter 31), in Developing Solid Oral Dosage Forms; edited by Yihong Qiu, Yisheng Chen, Geoff G.Z. Zhang, Lirong Liu, and William R. Porter, 2008. Mr. Smith has a BS in chemical engineering and a MS in food science from Iowa State University.
Greg Thiele worked at Mallinckrodt for several years as quality supervisor for the acetaminophen production facility before joining Micromeritics in 1994 as a regional sales and support engineer. In 2004, he became the general manager of Micromeritics Analytical Services, a contract testing laboratory for Micromeritics, where he works with a wide range of pharmaceutical products. In 2014, he became general manager for Micromeritics' European operations, where the company holds six direct offices. In January 2017, he started working as general manager for North and South America, including lab service operations.